TipRanksTop Financial ExpertsInsidersAtlas Venture Fund IX, L.P.

Atlas Venture Fund IX, L.P. Insider Profile

4 Followers
Atlas Venture Fund IX, L.P., Ten Percent Owner at Intellia Therapeutics, holds 2.95M shares in Surface Oncology (Ticker: SURF), holds 3.36M shares in Cogent Biosciences (Ticker: COGT), holds 3.73M shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Atlas Venture Fund IX, L.P. Sold ― shares of Surface Oncology on Dec 21, 2020 for an estimated value of 30.77M.
Atlas Venture Fund IX, L.P.

Atlas Venture Fund IX, L.P.
Intellia Therapeutics (NTLA)
Ten Percent Owner

Ranked #75,112 out of 78,905 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-73.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$308M
76.99%
13.33%
9.69%
A breakdown of Atlas Venture Fund IX, L.P.'s holdings

Insider Roles

Intellia Therapeutics
(NTLA)
Ten Percent Owner
Cogent Biosciences
(COGT)
Ten Percent Owner
Surface Oncology
(SURF)
Ten Percent Owner
Roles that Atlas Venture Fund IX, L.P. holds in companies

Most Profitable Insider Trade

Stock:
Cogent Biosciences
(COGT)
Rating:Informative Buy
Date:Apr 03, 2018 - Apr 03, 2019
Return:-59.30%
The most profitable trade made by Atlas Venture Fund IX, L.P.

Atlas Venture Fund IX, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intellia Therapeutics
Jul 11, 2017
Ten Percent Owner
Informative Sell
$2.43M
$236.95M
Cogent Biosciences
Apr 03, 2018
Ten Percent Owner
Uninformative Buy
$41.01M
Surface Oncology
Dec 21, 2020
Ten Percent Owner
Informative Sell
$30.77M
$29.81M
List of latest transactions for each holding click on a transaction to see Atlas Venture Fund IX, L.P.'s performance on stock

Atlas Venture Fund IX, L.P. insider profile FAQ

What is the percentage of profitable transactions made by Atlas Venture Fund IX, L.P.?
The percentage of profitable transactions made by Atlas Venture Fund IX, L.P. is 0%.
    What is the average return per transaction made by Atlas Venture Fund IX, L.P.?
    The average return per transaction made by Atlas Venture Fund IX, L.P. is -73.90%.
      What stocks does Atlas Venture Fund IX, L.P. hold?
      Atlas Venture Fund IX, L.P. holds: NTLA, COGT, SURF stocks.
        What was Atlas Venture Fund IX, L.P.’s latest transaction?
        Atlas Venture Fund IX, L.P. latest transaction was an Informative Sell of $30.77M.
          What was Atlas Venture Fund IX, L.P.'s most profitable transaction?
          Atlas Venture Fund IX, L.P.’s most profitable transaction was an Informative Buy of COGT stock on April 3, 2018. The return on the trade was -59.30%.
            What is Atlas Venture Fund IX, L.P.'s role in Intellia Therapeutics?
            Atlas Venture Fund IX, L.P.'s role in Intellia Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.